Organon Pharma Indonesia Tbk. vs Victoria Care Indonesia Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Victoria Care Indonesia Tbk. trades at Rp1,115 (market cap 7.45T, 5.14M 24h volume). The key difference: Victoria Care Indonesia Tbk. is far larger — about 71.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | VICI | |
|---|---|---|
Market Cap | 104.4B | 7.45T |
Volume | — | 5.14M |
Lot | — | 51.39K |
Turnover | — | 5.61B |
Average Price | — | 1,091.96 |
Value | — | 5.61B |
Indicative Equilibrium Price | — | 1,115 |
Indicative Equilibrium Volume | — | 3.32K |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Victoria Care Indonesia Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 32 of Marina Soewana, S.H., on April 20, 2006. The Company started its commercial operations in 2007.
Read more on VICI →